News in the Life Sciences Industry

SAN DIEGO, Feb. 7, 2019 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its second quarter ended December 31, 2018.

EL SEGUNDO, Calif., Feb. 7, 2019 /PRNewswire/ -- Health-science nutrition company Liquid I.V. has donated over 1 million servings of their hydration product to communities in need around the world - a number they reached this week on the heels of their rapid growth in 2018. As part of their 1-for-1... Read more ››

DUBLIN, Feb. 7, 2019 /PRNewswire/ --

SAN RAFAEL, Calif., Feb. 7, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that an ongoing open-label extension study treating patients with Brineura(®) (cerliponase alfa) continued to show a reduced rate of decline compared to a natural history cohort of CLN2... Read more ››

SILVER SPRING, Md., Feb. 7, 2019 /PRNewswire/ -- A key element of the U.S. Food and Drug Administration's mission is focused on helping to ensure that all products we regulate, including drugs available to consumers, are safe and of high quality. This means working to ensure greater accountability... Read more ››

SAN DIEGO, Feb. 7, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will participate in the Guggenheim Healthcare Talks Idea Forum & Oncology Day in New York on Thursday, February 14(th) at 11:00 a.m. ET/ 8:00 a.m. PT. Chris LeMasters,... Read more ››

SAN DIEGO, Feb. 7, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will present preclinical and early... Read more ››

NEW YORK, Feb. 7, 2019 /PRNewswire/ -- For more than three decades, American Skin Association (ASA) and its affiliates have funded more than $50 million in grants to address the causes and treatments of melanoma, vitiligo, and psoriasis, as well as other skin diseases, and to search for much-needed... Read more ››

MEMPHIS, Tenn., Feb. 7, 2019 /PRNewswire/ -- Le Bonheur Children's Hospital cardiologists have implanted the world's first commercially-approved medical device for transcatheter patent ductus arteriosus closure in the tiniest babies (weighing as little as two pounds). The Amplatzer Piccolo(TM)... Read more ››

NEW YORK, Feb. 7, 2019 /PRNewswire/ --

NEW YORK, Feb. 7, 2019 /PRNewswire/ --

NEW YORK, Feb. 7, 2019 /PRNewswire/ -- About this market
Advances in diagnosis of antifungal resistant pathogens to drive market growth. Although the currently available antifungal drugs are killing various species of candidiasis, some fungi can develop the ability to defend these... Read more ››

LOS ANGELES, Feb. 7, 2019 /PRNewswire/ -- Colorado-based health company Empirisome(TM) recently added a full product line to its B2B offerings. Empirisome's new line is a portfolio of empirically studied liposomal products backed by Read more ››

WASHINGTON, Feb. 7, 2019 /PRNewswire/ -- Unity Health Care (Unity) welcomed Health and Human Services Secretary Alex Azar II, Surgeon General Vice Admiral Dr. Jerome Adams, and HRSA Administrator George Sigounas, Ph.D. to Unity's Parkside Health Center to discuss the Trump Administration's recently... Read more ››

REDWOOD CITY, Calif., Feb. 7, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the company will release its financial results for the fourth quarter and full... Read more ››